β-Glucan Assay Kit (Yeast and Mushroom) (Bottle 1) - RD

Hazard statements (CLP)

H334

Code

Statements

H334

May cause allergy or asthma symptoms or breathing difficulties if inhaled

SECTION 2: Hazards identification

According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture

Adverse physicochemical, human health and environmental effects

May cause allergy or asthma symptoms or breathing difficulties if inhaled

Hazard pictograms

GHS08

Signal word

Danger

Contains

Amylase, gluco-; β-Fructofuranosidase; Trehalase; ALPHA-AMYLASE (bacterial)

Hazard statements

H334 - May cause allergy or asthma symptoms or breathing difficulties if inhaled.

Precautionary statements

P261 - Avoid breathing dust/fume/gas/mist/vapours/spray. P304+P340 - IF INHALED: Remove person to fresh air and keep comfortable for breathing. P342+P311 - If experiencing respiratory symptoms: Call a POISON CENTER or doctor.

2.3 Other hazards

Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII Component Substance(s) not meeting the PBT criteria of REACH Sodium azide (26628-22-8)(¹), Glycerin (56-81-5) regulation, in accordance with Annex XIII Substance(s) not meeting the vPvB criteria of REACH Sodium azide (26628-22-8)(¹), Glycerin (56-81-5) regulation, in accordance with Annex XIII (¹) Substance(s) in concentration below 0.1 % and displayed on a voluntary basis The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %

2.1 Classification of the substance or mixture

Classification according to Regulation (EC) No. 1272/2008 [CLP] Respiratory sensitisation, Category 1 H334 Full text of H- and EUH-statements: see section 16 Adverse physicochemical, human health and environmental effects May cause allergy or asthma symptoms or breathing difficulties if inhaled. 2.2. Label elements Labelling according to Regulation (EC) No. 1272/2008 [CLP] Hazard pictograms (CLP) : GHS08 Signal word (CLP) : Danger Contains : Amylase, gluco-; β-Fructofuranosidase; Trehalase; ALPHA-AMYLASE (bacterial) Hazard statements (CLP) : H334 - May cause allergy or asthma symptoms or breathing difficulties if inhaled. Precautionary statements (CLP) : P261 - Avoid breathing dust/fume/gas/mist/vapours/spray. P304+P340 - IF INHALED: Remove person to fresh air and keep comfortable for breathing. P342+P311 - If experiencing respiratory symptoms: Call a POISON CENTER or doctor. 2.3. Other hazards Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII Component Substance(s) not meeting the PBT criteria of REACH Sodium azide (26628-22-8)(¹), Glycerin (56-81-5) regulation, in accordance with Annex XIII Substance(s) not meeting the vPvB criteria of REACH Sodium azide (26628-22-8)(¹), Glycerin (56-81-5) regulation, in accordance with Annex XIII (¹) Substance(s) in concentration below 0.1 % and displayed on a voluntary basis The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 % SECTION 3: Composition/information on ingredients 3.2. Mixtures Name Product identifier % Classification according to Regulation (EC) No. 1272/2008 [CLP] Glycerin CAS-No.: 56-81-5 ≥ 50 – < 75 Not classified substance with national workplace exposure limit(s) EC-No.: 200-289-5 (BE, CZ, DE, EE, ES, FI, FR, GB, GR, HR, PL, SI, SK, CH) Amylase, gluco- CAS-No.: 9032-08-0 ≥ 10 – < 15 Resp. Sens. 1, H334 EC-No.: 231-984-1 Trehalase CAS-No.: 9025-52-9 ≥ 1 – < 5 Resp. Sens. 1, H334 EC-No.: 259-416-8 ALPHA-AMYLASE (bacterial) CAS-No.: 9000-85-5 ≥ 1 – < 5 Resp. Sens. 1, H334 EC-No.: 232-560-9 Aquatic Chronic 4, H413 β-Fructofuranosidase CAS-No.: 9001-57-4 ≥ 0.1 – < 0.5 Resp. Sens. 1, H334 EC-No.: 232-615-7 Sodium azide CAS-No.: 26628-22-8 < 0.1 Acute Tox. 2 (Oral), H300 substance with national workplace exposure limit(s) EC-No.: 247-852-1 Acute Tox. 1 (Dermal), H310 (AT, BE, BG, CY, CZ, DE, DK, EE, ES, FI, FR, GB, EC Index-No.: 011-004-00-7 Acute Tox. 2 (Inhalation:dust,mist), H330 GI, GR, HR, HU, IE, IT, LT, LU, LV, MT, NL, PL, PT, STOT RE 1, H372 RO, SE, SI, SK, AL, IS, NO, MK, RS, CH, TR); Aquatic Acute 1, H400 substance with a Community workplace exposure limit Aquatic Chronic 1, H410 Full text of H- and EUH-statements: see section 16 SECTION 4: First aid measures 4.1. Description of first aid measures First-aid measures general : Call a poison center or a doctor if you feel unwell. First-aid measures after inhalation : Remove person to fresh air and keep comfortable for breathing. If experiencing respiratory symptoms: Call a poison center or a doctor. First-aid measures after skin contact : Wash skin with plenty of water. First-aid measures after eye contact : Rinse eyes with water as a precaution. First-aid measures after ingestion : Call a poison center or a doctor if you feel unwell. Self protection of the first-aider : First aid workers will be equipped with suitable personal protective equipment. 4.2. Most important symptoms and effects, both acute and delayed Symptoms/effects after inhalation : May cause allergy or asthma symptoms or breathing difficulties if inhaled. Symptoms/effects after skin contact : None under normal conditions.